University of California, San Diego Perlman Ambulatory Center
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hata, Tissa
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26
TIME-1, NCT05177328: Targeted Investigation of Microbiome Elimination

Terminated
1
21
US
S. hominis A 9 Product, ShA9, Placebo, Placebo for S. hominis A 9 Product
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network
Atopic Dermatitis
08/23
10/23

Download Options